financetom
Business
financetom
/
Business
/
What's Going On With Spirit Airlines Stock Wednesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Spirit Airlines Stock Wednesday?
Nov 13, 2024 11:04 AM

Spirit Airlines, Inc. ( SAVE ) stock is moving lower on Wednesday after the company filed a Form 12b-25 with the Securities and Exchange Commission (SEC).

The Details: Spirit filed the form, signaling it cannot submit its 2024 third-quarter earnings on time, as the company has diverted resources from reviewing and completing financial statements to ongoing debt restructuring discussions.

The talks are specifically in regard to about $1 billion worth of senior secured notes due in 2025 and $500 million worth of convertible senior notes due in 2026. Besides the debt restructuring conversations, the airline is exploring alternatives and other ways to improve liquidity.

The company said that its conversations with noteholders have been productive. It also warned that if an agreement is reached it could lead to cancellation of Spirit’s existing equity.

Although the company cannot file its third-quarter earnings on time, it did provide some financial estimates for the quarter. Specifically, the airline anticipates adjusted operating margin to fall by 12% compared to the same period last year, citing revenue challenges and rising expenses.

Spirit estimates that total operating revenues decreased by $61 million year-over-year, while total adjusted operating expenses increased by approximately $52 million.

This comes after Spirit’s merger conversations with Fronter Group Holdings Inc. fell through.

See Also: Occidental Petroleum Set To Release Q3 Earnings: Can It Justify Warren Buffett’s Vote Of Confidence?

SAVE Price Action: At the time of publication, Spirit stock is moving 57.6% lower at $1.36, according to data from Benzinga Pro.

Image: Courtesy of Spirit, Inc.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Reitmans (Canada) Breaks Even in its Fiscal Fourth Quarter
Reitmans (Canada) Breaks Even in its Fiscal Fourth Quarter
Apr 18, 2024
04:53 PM EDT, 04/18/2024 (MT Newswires) -- Reitmans (Canada) ( RTMNF ) on Thursday said it broke even it in its fiscal fourth-quarter, posting no profit despite higher revenue. The clothing retailer posted no profit or loss in the quarter ended Feb.3, down from a profit of C$27.5 million in the year-prior period. Revenue rose 3.8% to C$221 million from...
T. Rowe Price says 2018 Tesla pay aligned with investor interests
T. Rowe Price says 2018 Tesla pay aligned with investor interests
Apr 18, 2024
April 18 (Reuters) - Mutual fund firm T. Rowe Price ( TROW ) said Elon Musk's record-breaking 2018 pay package from Tesla demonstrated strong alignment with the interests of investors at the electric carmaker. The comments from the 10th-largest Tesla investor mark important support after a Delaware judge in January voided the $56 billion package as being unfair to investors...
Medical device maker Intuitive beats estimates on strong demand for surgical robots
Medical device maker Intuitive beats estimates on strong demand for surgical robots
Apr 18, 2024
(Reuters) - Intuitive Surgical ( ISRG ) beat Wall Street estimates for first-quarter profit and revenue on Thursday, riding on higher demand for its robots used in minimally invasive procedures. Investor expectations around the performance of medical device makers have been heightened since last November, as people, especially older adults, opted for medical procedures deferred during the pandemic. Intuitive, which...
Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing
Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing
Apr 18, 2024
04:52 PM EDT, 04/18/2024 (MT Newswires) -- Jaume Pons, Director, President & Chief Scientific Officer, on April 16, 2024, sold 50,000 shares in Alx Oncology Holdings ( ALXO ) for $710,195. Following the Form 4 filing with the SEC, Pons has control over a total of 604,205 shares of the company, with 604,205 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1810182/000141588924011128/xslF345X03/form4-04182024_080417.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved